• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 234-248 of 249 results

2072 Exhibit: Dainippon Sumitomo Pharma Co, Ltd, Supplementary Financial Dataf...

Document IPR2020-01053, No. 2072 Exhibit - Dainippon Sumitomo Pharma Co, Ltd, Supplementary Financial Datafor Year Ended March 31, 2014 (P.T.A.B. Mar. 11, 2021)

cite Cite Document

1057 Exhibit: Petitioners Demonstrative Exhibits

Document IPR2020-01053, No. 1057 Exhibit - Petitioners Demonstrative Exhibits (P.T.A.B. Aug. 9, 2021)

cite Cite Document

1053 Exhibit: Claim Construction Brief at Federal Circuit

Document IPR2020-01053, No. 1053 Exhibit - Claim Construction Brief at Federal Circuit (P.T.A.B. Jun. 10, 2021)

cite Cite Document

1056 Exhibit: Morrison

Document IPR2020-01053, No. 1056 Exhibit - Morrison (P.T.A.B. Jun. 10, 2021)

cite Cite Document

2098 Exhibit: Zhuo et al, Topiramate and Metformin Are Effective Add OnTreatmen...

Document IPR2020-01053, No. 2098 Exhibit - Zhuo et al, Topiramate and Metformin Are Effective Add OnTreatments in Controlling Anti Psychotic Weight Gain (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2073 Exhibit: Jancin, Newer Atypical Antipsychotics Draw Praise

Document IPR2020-01053, No. 2073 Exhibit - Jancin, Newer Atypical Antipsychotics Draw Praise (P.T.A.B. Mar. 11, 2021)

cite Cite Document

1052 Exhibit: Claim Construction Brief in District Court

Document IPR2020-01053, No. 1052 Exhibit - Claim Construction Brief in District Court (P.T.A.B. Jun. 10, 2021)

cite Cite Document

1051 Exhibit: Supplemental Declaration Dr Kosten, MD

Document IPR2020-01053, No. 1051 Exhibit - Supplemental Declaration Dr Kosten, MD (P.T.A.B. Jun. 10, 2021)

cite Cite Document

2135 Exhibit: Hummel et al, Clozapine as Add On Medication in the MaintenanceTr...

Document IPR2020-01053, No. 2135 Exhibit - Hummel et al, Clozapine as Add On Medication in the MaintenanceTreatment of Bipolar and Schizoaffective Disorder (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2001 Exhibit: History of the discovery and clinical introduction of chlorpromazine

Document IPR2020-01053, No. 2001 Exhibit - History of the discovery and clinical introduction of chlorpromazine (P.T.A.B. Sep. 18, 2020)

cite Cite Document

2050 Exhibit: Lieberman et al, Effectiveness of Antipsychotic Drugs in Patientswith...

Document IPR2020-01053, No. 2050 Exhibit - Lieberman et al, Effectiveness of Antipsychotic Drugs in Patientswith Chronic Schizophrenia (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2055 Exhibit: Pacher et al, Cardiovascular Side Effects of New Antidepressants an...

Document IPR2020-01053, No. 2055 Exhibit - Pacher et al, Cardiovascular Side Effects of New Antidepressants andAntipsychotics (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2141 Exhibit: News Release FDA Approves Once Daily Latuda lurasidoneHCl for Tr...

Document IPR2020-01053, No. 2141 Exhibit - News Release FDA Approves Once Daily Latuda lurasidoneHCl for Treatment of Patients with Schizophrenia (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2085 Exhibit: Ng Mak et al, Efficacy and Metabolic Effects of Lurasidone VersusBre...

Document IPR2020-01053, No. 2085 Exhibit - Ng Mak et al, Efficacy and Metabolic Effects of Lurasidone VersusBrexpiprazole in Schizophrenia (P.T.A.B. Mar. 11, 2021)

cite Cite Document

2048 Exhibit: Symbyax�� Label

Document IPR2020-01053, No. 2048 Exhibit - Symbyax�� Label (P.T.A.B. Mar. 11, 2021)

cite Cite Document
<< 1 2 3 4 5 ... 16 17 18 >>